KRYS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

SPRZEDAż 2911 min ago

@ $160.10

Wydano: 3 geg. 2024 @ 21:14

Zwrot: 0.62%

Poprzedni sygnał: geg. 3 - 18:12

Poprzedni sygnał: Kupno

Zwrot: -0.50 %

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):
Our systems believe the stock currently is overvalued by 0.00% compare to its pairs and should correct downwards.

Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States...

Stats
Dzisiejszy wolumen	453 065
Średni wolumen	386 906
Kapitalizacja rynkowa	4.56B
EPS	$0 ( 2024-02-26 )
Następna data zysków	( $0.200 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	413.08
ATR14	$6.85 (4.26%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-11	Krishnan Suma	Sell	2 146	Common Stock
2024-03-11	Krishnan Suma	Sell	2 254	Common Stock
2024-03-11	Krishnan Suma	Sell	5 109	Common Stock
2024-03-11	Krishnan Suma	Sell	8 002	Common Stock
2024-03-11	Krishnan Suma	Sell	2 816	Common Stock

INSIDER POWER
4.49
Last 100 transactions
Buy: 214 300 \| Sell: 194 377

Korelacja (AI algo v.1.1b): Overvalued: 0.00% $160.84 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Wolumen Korelacja

Długi: 0.66 (moderate)

Krótki: 0.84 (strong)

Signal:(43) Same movement expected

Krystal Biotech Inc Korelacja

10 Najbardziej pozytywne korelacje
SCR	0.943
APLT	0.943
TRVI	0.937
LMNL	0.935
SCPL	0.929
NXGN	0.929
BRKR	0.927
BWC	0.925
HOOD	0.925
IMGN	0.924

10 Najbardziej negatywne korelacje
ROKU	-0.933
BRQS	-0.919
SABR	-0.917
DBX	-0.908
FIVN	-0.906
MFIN	-0.906
DCRC	-0.905
PEAR	-0.902
RAPT	-0.894
CYAN	-0.893

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Krystal Biotech Inc Korelacja - Waluta/Towar

0.76
( moderate )

0.55
( weak )

0.00
( neutral )

0.34
( neutral )

-0.76
( moderate negative )

Krystal Biotech Inc Finanse

Annual	2023
Przychody:	$50.70M
Zysk brutto:	$42.60M (84.02 %)
EPS:	$0.400

FY	2023
Przychody:	$50.70M
Zysk brutto:	$42.60M (84.02 %)
EPS:	$0.400

FY	2022
Przychody:	$0
Zysk brutto:	$-4.05M (0.00 %)
EPS:	$-5.49

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-3.13

Financial Reports:

No articles found.

Krystal Biotech Inc

Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome. Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx product. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.

Aktualne aktualizacje dla Krystal Biotech Inc [KRYS]

Upcoming Earnings Alert